Reprometabolic Syndrome Mediates Subfertility in Obesity

Open-label trial (2 arms), sponsored by University of Colorado Denver. Primary endpoints: Change in LH Pulse Amplitude Before and After Acute or Chronic FFA Administration at 4 hours and Change in Steady State Amount of Glucose Metabolized at the Set Insulin Infusion Rate Under Euglycemic Conditions at 30 minutes. Started Jun 2016; status: active, not recruiting.